Combination use of ferulic acid, ligustrazine and tetrahydropalmatine inhibits the growth of ectopic endometrial tissue: a multi-target therapy for endometriosis rats

J Ethnopharmacol. 2014 Feb 12;151(3):1218-1225. doi: 10.1016/j.jep.2013.12.047. Epub 2014 Jan 2.

Abstract

Ethnopharmacological relevance: Ferulic acid (FA), ligustrazine (LZ) and tetrahydropalmatine (THP) are separately isolated from Chinese Angelica, Szechwan Lovage Rhizome and Rhizoma in the Jiawei-Foshou-San formula, a popular traditional Chinese medicine for irregular menses. It has been reported that the combination use of FA+LZ+THP has similar effect on endometriosis, but the underlying mechanisms are unclear. This study was to investigate the combination effects and mechanisms of FA+LZ+THP on endometriosis rats.

Materials and methods: Fifty endometriosis rats were intragastricly treated with FA+LZ+THP for 4 wk. The volume of ectopic endometrial tissue was measured to evaluate the effects. Then the changes in hypothalamic-pituitary-ovarian axis and ERE pathway were indicated by the levels of E2, GnRH, FSH and LH, and the expressions of ER, HSP90 and COX-2, respectively. In addition, peritoneal macrophages of each rat were cultured in vitro and treated with (FA+LZ+THP)-medicated serum for 24h. The proliferation and phagocytosis abilities, the levels of IL-1β and TNF-α, and the expression of IκBα were then measured for the changes of peritoneal macrophage activities.

Results: Combination use of FA+LZ+THP diminished the volume of the ectopic endometrial tissues (P<0.05 or P<0.01). It also decreased the E2 level, suppressed the expression of GnRH, FSH and LH, and decreased the protein expression of ER, HSP90 and COX-2 (all P<0.05 or P<0.01). The phagocytosis ability of peritoneal macrophage was enhanced by (FA+LZ+THP)-medicated serum (P<0.05) with no change of proliferation (P>0.05). Moreover, IL-1β and TNF-α were downregulated (both P<0.05 or P<0.01) and IκBα was upregulated by the (FA+LZ+THP)-medicated serum (P<0.01).

Conclusions: The combination use of FA, LZ and THP could inhibit the growth of ectopic endometrial tissue in endometriosis rats. It might be related to the down-regulation of hypothalamic-pituitary-ovarian axis, the amelioration in ERE pathway and the improvement of peritoneal macrophage activities.

Keywords: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; An internal control used in Western Blot; CLIA; CMC-Na; COX-2; Carboxymethycellulose (PubChem CID: 6328154); Chemiluminescent Immunoassay; Cycloxygenase-2; DAB; Diaminobenzidine; Diaminobenzidine (PubChem CID: 7071); E(2); ECL; ELISA; ER; ERE; Endometriosis; Enhanced chemiluminescence; Enzyme linked immunosorbent assay; Estradiol; Estradiol (PubChem CID: 5757); Estrogen receptor; Estrogen response element; FA; FBS; FSH; Ferulic acid; Ferulic acid (PubChem CID: 445858); Fetal bovine serum; Follicle-stimulating hormone; GTN; Gestrinone; Gestrinone (PubChem CID: 27812); GnRH; Gonadotropin-releasing hormone; HRP; HSP90; Heat-shock protein 90; Horseradish peroxidase; IL-1β; IgG; Immunoglobulin G; Inhibitor of nuclear factor-κB; Interleukin-1β; IκBα; LH; LPS; LZ; Ligustrazine; Ligustrazine (PubChem CID: 14296); Lipopolysaccharide; Lipopolysaccharide (PubChem CID: 11970143); Luteinizing hormone; MTT; NF-κB; NP-40; Nonyl phenoxypolyethoxylethanol; Nuclear transcription factor-κB; PAGE; PBS; PMSF; PVDF; Phenylmethanesulfonyl fluoride; Phosphate buffered saline; Polyacrylamide gel electrophoresis; Polyvinylidene difluoride; RIPA; RPMI; Radio immunoprecipitation assay; Rats; Roswell Park memorial institute; SDS; SP; Sodium Carboxymethycellulose; Sodium dodecyl sulfate; Sodium dodecyl sulfate (PubChem CID: 3423265); Streptavidin–peroxidase; TBST; THP; TNF-α; Tetrahydropalmatine; Tetrahydropalmatine (PubChem CID: 72301); Tris-buffered saline and Tween 20; Tumor necrosis factor; β-actin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Berberine Alkaloids / therapeutic use*
  • Choristoma / drug therapy
  • Choristoma / metabolism
  • Coumaric Acids / therapeutic use*
  • Drug Therapy, Combination
  • Endometriosis / drug therapy*
  • Endometriosis / metabolism
  • Endometrium / drug effects
  • Endometrium / growth & development
  • Endometrium / metabolism
  • Estradiol / blood
  • Female
  • Follicle Stimulating Hormone / metabolism
  • Gonadotropin-Releasing Hormone / metabolism
  • I-kappa B Proteins / metabolism
  • Interleukin-1beta / metabolism
  • Luteinizing Hormone / metabolism
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / physiology
  • NF-KappaB Inhibitor alpha
  • Phagocytosis / drug effects
  • Pyrazines / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Berberine Alkaloids
  • Coumaric Acids
  • I-kappa B Proteins
  • Interleukin-1beta
  • Nfkbia protein, rat
  • Pyrazines
  • Tumor Necrosis Factor-alpha
  • NF-KappaB Inhibitor alpha
  • Gonadotropin-Releasing Hormone
  • tetrahydropalmatine
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • ferulic acid
  • tetramethylpyrazine